Dynavax Technologies Corp. (DVAX)
NCM · Common · CUSIP 268158201
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for DVAX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
268158201 (prev. 268158102 )
Market Cap
Small Cap · $434 Million
IPO
2/19/2004 · $7.50/share
Business: Dynavax Technologies Corp. is a fully-integrated biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation to develop cutting-edge vaccines.
Notes: November 7, 2014 -- Dynavax Technologies Corp. will be effecting a 1-10 reverse stock split effective at the opening of business on Monday, November 10, 2014. In conjunction with the reverse split, the CUSIP number will change to 268158201.

Company Contact

CEO
Ryan Spencer
CFO
Michael S. Ostrach
Headquarters
2100 Powell Street, Suite 900, Emeryville, CA 94608
Phone
510-848-5100 · Toll-Free 877-848-5100
Fax
510-848-1327
Investor Relations
Nicole Arndt · 510-665-7264 · narndt@dynavax.com
General Email
IR@dynavax.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »